IBD vs VXUS
IBD vs VXUS
Inspire Corporate Bond ETF vs Vanguard Total International Stock ETF
Quick Verdict
VXUS has a lower expense ratio. VXUS delivered stronger 1-year returns. VXUS offers more diversification with 7861 holdings.
Side-by-Side Comparison
| Metric | IBD | VXUS | Winner |
|---|---|---|---|
| Expense Ratio | 0.43% | 0.05% | |
| AUM | $485M | $156.5B | |
| Dividend Yield | 4.26% | 2.60% | |
| Holdings | 251 | 8,747 | |
| YTD Return | -0.13% | +14.57% | |
| 1Y Return | +2.47% | +27.82% | |
| 3Y Return (annualized) | +4.83% | +19.27% | |
| 5Y Return (annualized) | +1.03% | +9.28% | |
| Volatility (annualized) | 5.0% | 15.1% | |
| Max Drawdown | -16.3% | -39.9% | |
| Fund Family | Inspire ETFs | Vanguard (US) | |
| Category | Fixed Income | Equity | |
| Inception | Jul 10, 2017 | Jan 26, 2011 |
IBD vs VXUS Performance
Inspire Corporate Bond ETF (IBD) is a ETF from Inspire ETFs and Vanguard Total International Stock ETF (VXUS) is a ETF from Vanguard (US). Over the past year IBD returned +2.47% while VXUS returned +27.82%. Year to date, IBD is down 0.13% versus a gain of 14.57% for VXUS.
Over three years, IBD compounded at +4.83% per year against +19.27% for VXUS; over five years the annualized figures are +1.03% and +9.28% respectively. Across the full 9-year window we track, VXUS has the edge at +4.86% annualized vs +1.16%. Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
VXUS has been the more volatile fund, with annualized monthly volatility of 15.1% compared with 5.0% for IBD. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -16.3% for IBD and -39.9% for VXUS. Drawdown depth is worth weighing if you expect to sell during market stress rather than ride it out.
The two funds' monthly returns correlate at 0.67. They move independently enough that combining them can meaningfully diversify a portfolio.
Fees and Cost Over Time
IBD charges 0.43% per year while VXUS charges 0.05%. On a $10,000 position that is $43 vs $5 annually, a gap of $38 per year that compounds over a long holding period. On income, IBD currently yields 4.26% against 2.60% for VXUS.
Holdings Overlap
IBD and VXUS share 0 holdings out of 8108 unique holdings combined, representing a 0.0% weight overlap.
Moderate overlap means holding both could provide meaningful diversification benefits.
Frequently Asked Questions
Which is cheaper, IBD or VXUS?
IBD has an expense ratio of 0.43% while VXUS charges 0.05%. VXUS is the cheaper option. On a $10,000 investment, that is $38 per year of difference.
Which performed better, IBD or VXUS?
Over the past year IBD returned +2.47% vs +27.82% for VXUS, so VXUS leads on 1-year performance. Over the longest common window we track (9 years), IBD annualized +1.16% vs +4.86% for VXUS. Past performance does not guarantee future results.
Which is riskier, IBD or VXUS?
VXUS has been the more volatile fund at 15.1% annualized versus 5.0% for IBD. Worst drawdown: IBD -16.3% vs VXUS -39.9%.
Should I hold both IBD and VXUS?
IBD and VXUS have a monthly-return correlation of 0.67, so combining them can provide real diversification depending on your allocation goals.
What is the holdings overlap between IBD and VXUS?
IBD and VXUS share 0 common holdings with a 0.0% weight overlap. Combined, they hold 8108 unique securities.
Which pays a higher dividend, IBD or VXUS?
IBD yields 4.26% while VXUS yields 2.60%, so IBD currently pays the higher dividend yield.
Popular ETF Comparisons
Get Full ETF Analytics
Access complete holdings data, overlap analysis, screener tools, and more with FundXLS.